Efficacy of sulphadoxine-pyrimethamine for intermittent preventive treatment of malaria in pregnancy, Mansa, Zambia

Malaria Journal

Volumn 13, Issue 1, 2014, Pages

  Tan, Kathrine R ^a   Katalenich, Bonnie L ^b   Mace, Kimberly E ^a   Nambozi, Michael ^c   Taylor, Steve M ^d   Meshnick, Steven R ^e   Wiegand, Ryan E ^a   Chalwe, Victor ^f   Filler, Scott J ^g   Kamuliwo, Mulakwa ^h   Craig, Allen S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Tropical Diseases Research Centre Ndola   (Zambia)

^d DUKE UNIVERSITY MEDICAL CENTER   (United States)

^e University of North Carolina at Chapel Hill   (United States)

^f Maina Soko Military Hospital   (Zambia)

^g TUBERCULOSIS AND MALARIA   (Switzerland)

^h National Malaria Control Centre   (Zambia)

Author keywords

Intermittent preventive treatment; Malaria; Pregnancy; Sulphadoxine pyrimethamine

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; DIHYDROFOLATE REDUCTASE; DIHYDROPTEROATE SYNTHASE; GLUTAMATE RICH PROTEIN; GLUTAMIC ACID; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; PYRIMETHAMINE PLUS SULFADOXINE; UNCLASSIFIED DRUG; ANTIMALARIAL AGENT; DRUG COMBINATION; FANASIL, PYRIMETHAMINE DRUG COMBINATION; PYRIMETHAMINE; SULFADOXINE;

ADULT; ANTIMALARIAL DRUG RESISTANCE; ANTIMALARIAL DRUG SUSCEPTIBILITY; ARTICLE; ASYMPTOMATIC INFECTION; BED NET; BLOOD SMEAR; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENE LOCUS; GENOTYPE; GESTATIONAL AGE; HAPLOTYPE; HUMAN; INDOOR RESIDUAL SPRAYING; MAJOR CLINICAL STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MALARIA RAPID TEST; MICROSCOPY; NONHUMAN; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PARASITE PREVALENCE; PARASITEMIA; PLASMODIUM FALCIPARUM; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANT WOMAN; PRIMIGRAVIDA; REINFECTION; RURAL AREA; SURVIVAL; TEST STRIP; YOUNG ADULT; ZAMBIA; ADOLESCENT; ANIMAL; DRUG COMBINATION; DRUG EFFECTS; DRUG RESISTANCE; MALARIA, FALCIPARUM; MUTATION; PREGNANCY COMPLICATIONS, INFECTIOUS; PROCEDURES; TREATMENT FAILURE;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; DRUG COMBINATIONS; DRUG RESISTANCE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALARIA, FALCIPARUM; MUTATION; PLASMODIUM FALCIPARUM; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PYRIMETHAMINE; SULFADOXINE; SURVIVAL ANALYSIS; TREATMENT FAILURE; YOUNG ADULT; ZAMBIA;

EID: 84902551898     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-13-227     Document Type: Article

References (36)

1. Quantifying the number of pregnancies at risk of malaria in 2007: a demographic study. Dellicour S, Tatem AJ, Guerra CA, Snow RW, ter Kuile FO, PLoS Med 2010 7 1000221 10.1371/journal.pmed.1000221 20126256
2. Epidemiology and burden of malaria in pregnancy. Desai M, ter Kuile FO, Nosten F, McGready R, Asamoa K, Brabin B, Newman RD, Lancet Infect Dis 2007 7 93 104 10.1016/S1473-3099(07)70021-X 17251080
3. World Health Organization, A Strategic Framework for Malaria Prevention and Control during Pregnancy in the African Region Brazzaville: Regional Office for Africa 2004 AFR/MAL/04/01
4. Central Statistical Office (CSO) MoHM, Zambia Demographic and Health Survey 2007 Calverton, Maryland, USA: CSO and Macro International Inc 2009
5. Central Board of Health (Zambia), Guidelines for the Diagnosis and Treatment of Malaria in Zamiba Lusaka, Zambia: Central Board of Health 2003
6. Government of the Republic of Zambia MoH, Zambia National Malaria Indicator Survey Zambia: Zambia Ministry of Health 2008
7. Coverage of malaria protection in pregnant women in sub-Saharan Africa: a synthesis and analysis of national survey data. van Eijk AM, Hill J, Alegana VA, Kirui V, Gething PW, ter Kuile FO, Snow RW, Lancet Infect Dis 2011 11 190 207 10.1016/S1473-3099(10)70295-4 21273130
8. From chloroquine to artemether-lumefantrine: the process of drug policy change in Zambia. Sipilanyambe N, Simon JL, Chanda P, Olumese P, Snow RW, Hamer DH, Malar J 2008 7 25 10.1186/1475-2875-7-25 18230140
9. A systematic approach to the development of a rational malaria treatment policy in Zambia. Barat LM, Himonga B, Nkunika S, Ettling M, Ruebush TK, Kapelwa W, Bloland PB, Trop Med Int Health 1998 3 535 542 10.1046/j.1365-3156.1998. 00271.x 9705187
10. Therapeutic efficacy of artemether lumefantrine and sulphadoxine- pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Zambian children under five years. Hamainza B, Chanda P, Hawela M, Chizema-Kawesha E, Medical Journal of Zambia 2007 34 81 86
11. Decreasing Efficacy of Sulphadoxine-pyrimethamine (SP) in Zambian Children [Abstract 708]. Chanda P, Sikaala CH, Kapelwa W, 53rd Annual Meeting of the American Society of Tropical Medicine and Hygiene Miami Beach, FL: American Society of Tropical Medicine and Hygiene Vol 71 Suppl 4. pp. 209. 2004 209
12. Effect of sulfadoxine-pyrimethamine resistance on the efficacy of intermittent preventive therapy for malaria control during pregnancy: a systematic review. ter Kuile FO, van Eijk AM, Filler SJ, JAMA 2007 297 2603 2616 10.1001/jama.297.23.2603 17579229
13. Two-dose versus monthly intermittent preventive treatment of malaria with sulfadoxine-pyrimethamine in HIV-seropositive pregnant Zambian women. Hamer DH, Mwanakasale V, Macleod WB, Chalwe V, Mukwamataba D, Champo D, Mwananyanda L, Chilengi R, Mubikayi L, Mulele CK, Mulenga M, Thea DM, Gill CJ, J Infect Dis 2007 196 1585 1594 10.1086/522142 18008241
14. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RA, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721
15. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Harrington WE, Mutabingwa TK, Muehlenbachs A, Sorensen B, Bolla MC, Fried M, Duffy PE, Proc Natl Acad Sci U S A 2009 106 9027 9032 10.1073/pnas.0901415106 19451638
16. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D, PLoS One 2009 4 4569 10.1371/journal.pone.0004569 19238219
17. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Sirawaraporn W, Sathitkul T, Sirawaraporn R, Yuthavong Y, Santi DV, Proc Natl Acad Sci U S A 1997 94 1124 1129 10.1073/pnas.94.4.1124 9037017
18. Escalating Plasmodium falciparum antifolate drug resistance mutations in Macha, rural Zambia. Mkulama MA, Chishimba S, Sikalima J, Rouse P, Thuma PE, Mharakurwa S, Malar J 2008 7 87 10.1186/1475-2875-7-87 18495008
19. WHO, Basic Malaria Microscopy Part I: Learner's Guide Geneva: World Health Organization 1991
20. Genotyping of Plasmodium spp. Nested PCR. Snounou G, Methods Mol Med 2002 72 103 116 12125106
21. Therapeutic efficacy of artemether lumefantrine and sulphadoxine- pyrimethamine for treatment of uncomplicated Plasmodium falciparum malaria in Zambian children under five years. Hamainza BCP, Hawela P, Chizema-Kawesha E, Medical Journal of Zambia 2007 34 81 85
22. Nonparametric estimation from incomplete observations. Kaplan EL, Meier P, J Am Stat Assoc 1958 282 457 481
23. SAS Institute Inc, SAS Software Version 9.3 Cary, NC: SAS Institute Inc
24. Wickham H, ggplot2: Elegant Graphics for Data Analysis New York: Springer 2009
25. Antenatal receipt of sulfadoxine-pyrimethamine does not exacerbate pregnancy-associated malaria despite the expansion of drug-resistant Plasmodium falciparum: clinical outcomes from the QuEERPAM study. Taylor SM, Antonia AL, Chaluluka E, Mwapasa V, Feng G, Molyneux ME, ter Kuile FO, Meshnick SR, Rogerson SJ, Clin Infect Dis 2012 55 42 50 10.1093/cid/cis301 22441649
26. WHO, Methods for Surveillance of Antimalarial Drug Efficacy Geneva: World Health Organization 2009
27. National Malaria Control Centre, Guidelines for the Diagnosis and Treatment of Malaria Zambia: Zambia Ministry of Health 4 2014
28. Surveillance of molecular markers of Plasmodium falciparum resistance to sulphadoxine-pyrimethamine 5 years after the change of malaria treatment policy in Ghana. Duah NO, Quashie NB, Abuaku BK, Sebeny PJ, Kronmann KC, Koram KA, Am J Trop Med Hyg 2012 87 996 1003 10.4269/ajtmh.2012.12-0202 23045251
29. Molecular markers of resistance to sulphadoxine-pyrimethamine during intermittent preventive treatment of pregnant women in Benin. Bertin G, Briand V, Bonaventure D, Carrieu A, Massougbodji A, Cot M, Deloron P, Malar J 2011 10 196 10.1186/1475-2875-10-196 21767415
30. A randomized, controlled trial of intermittent preventive treatment with sulfadoxine-pyrimethamine, amodiaquine, or the combination in pregnant women in Ghana. Clerk CA, Bruce J, Affipunguh PK, Mensah N, Hodgson A, Greenwood B, Chandramohan D, J Infect Dis 2008 198 1202 1211 10.1086/591944 18752443
31. Rapid increase in the prevalence of sulfadoxine-pyrimethamine resistance among Plasmodium falciparum isolated from pregnant women in Ghana. Mockenhaupt FP, Bedu-Addo G, Eggelte TA, Hommerich L, Holmberg V, von Oertzen C, Bienzle U, J Infect Dis 2008 198 1545 1549 10.1086/592455 18834303
32. High rates of parasite recrudescence following intermittent preventive treatment with sulphadoxine-pyrimethamine during pregnancy in Benin. Moussiliou A, Sissinto-Savi De Tove Y, Doritchamou J, Luty AJ, Massougbodji A, Alifrangis M, Deloron P, Tuikue Ndam N, Malar J 2013 12 195 10.1186/1475-2875-12-195 23758883
33. Adaptive evolution and fixation of drug-resistant Plasmodium falciparum genotypes in pregnancy-associated malaria: 9-year results from the QuEERPAM study. Taylor SM, Antonia A, Feng G, Mwapasa V, Chaluluka E, Molyneux M, ter Kuile FO, Rogerson SJ, Meshnick SR, Infect Genet Evol 2012 12 282 290 10.1016/j.meegid.2011.11.006 22119749
34. Effectiveness of intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy on maternal and birth outcomes in machinga district, Malawi. Gutman J, Mwandama D, Wiegand RE, Ali D, Mathanga DP, Skarbinski J, J Infect Dis 2013 208 907 916 10.1093/infdis/jit276 23801600
35. Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis. Kayentao K, Garner P, van Eijk AM, Naidoo I, Roper C, Mulokozi A, MacArthur JR, Luntamo M, Ashorn P, Doumbo OK, ter Kuile FO, JAMA 2013 309 594 604 10.1001/jama.2012.216231 23403684
36. Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance. Harrington WE, Mutabingwa TK, Kabyemela E, Fried M, Duffy PE, Clin Infect Dis 2011 53 224 230 10.1093/cid/cir376 21765070